Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Acceleron Pharma (XLRN)

Acceleron Pharma (XLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Acceleron Pharma 128 SYDNEY STREET CAMBRIDGE MA 02139 USA

www.acceleronpharma.com P: 617-649-9200 F: 617-649-9988

Description:

Acceleron Pharma Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of protein therapeutics for cancer and rare diseases. Acceleron Pharma Inc. is based in Cambridge, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 10,931,634
Shares Outstanding, K 61,156
Annual Sales, $ 92,520 K
Annual Net Income, $ -166,030 K
Last Quarter Sales, $ 34,200 K
Last Quarter Net Income, $ -70,470 K
60-Month Beta 0.13
% of Insider Shareholders 1.70%
% of Institutional Shareholders 90.35%
Float, K 60,116
% Float 98.30%

Growth:

1-Year Return 61.15%
3-Year Return 252.84%
5-Year Return 370.64%
5-Year Revenue Growth 411.16%
5-Year Earnings Growth -52.08%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.16 on 11/04/21
Latest Earnings Date N/A
Earnings Per Share ttm -4.17
EPS Growth vs. Prev Qtr -8.57%
EPS Growth vs. Prev Year -72.73%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

XLRN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -32.11%
Return-on-Assets % -29.45%
Profit Margin % -179.45%
Debt/Equity 0.00
Price/Sales 118.77
Price/Cash Flow N/A
Price/Book 15.16
Book Value/Share 11.79
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar